17 June 2026
Welcome to this week's chemXplore Weekly. If one thread runs through the past seven days, it's consolidation. Dealmakers were busy: Olin and Huntsman unveiled an all-stock merger of equals to form OlinHuntsman, Mitsui Chemicals moved to acquire Ultradent as it builds dental materials into a third growth pillar, and Westlake added the Wilhelmshaven PVC and VCM plant to its European footprint. MAIRE/NEXTCHEM picked up metals-recovery capabilities through a 70% stake in ETEK, while Kemira and Stahl closed bolt-ons in water treatment and packaging coatings. For investors, the throughline is scale: producers are reaching for footprint, vertical integration and regulatory clearance as levers for margin resilience in a soft-demand market.
Beyond M&A, this issue covers electrified salt production, cross-border CCS momentum, and a wave of regulatory clarity—from ETS2 safeguards to the first new U.S. sunscreen active in 27 years. Read on for the full roundup.
Industry Trends
Sustainable Feedstocks & Circularity
Covestro’s EU‑backed Bio4PURConti targets continuous, drop‑in bio‑aniline for MDI chains, while acquired 70% of ETEK S.r.l. adds proprietary metals recovery across e‑waste, catalysts and batteries to MAIRE/NEXTCHEM’s suite. A Rotterdam FEED grant to BlueAlp and LBC Tank Terminals advances chemical recycling at tank‑terminal scale. At the smelter level, Aurubis Hamburg is capturing particulates and looping valuable metals back into production. Expect more hard‑asset integration that turns residues into feedstock while aligning with circularity targets.
Decarbonization & Low-Carbon Technologies
Nobian opened a fully electrified salt production facility in Mariager using MVR to cut energy and CO₂. Cross‑border CCS momentum grew with the Delta Rhine Corridor CO₂ pipeline MoU. In hydrogen, Petrobras and Finep launched a national electrolyzer program with local‑content requirements, while eSAF scale‑up advanced via Johnson Matthey Catalyst Technologies licensed for South Africa.
Regulatory Reforms & Compliance Challenges
Policy clarity is reshaping cost and market access. The EU agreed Market Stability Reserve changes to steady ETS2 ahead of 2028, with early auctions and frontloaded funding. New Jersey confirmed PureFive® resin qualifies as post-consumer recycled content, aiding brands as food‑contact PCR mandates start in 2027. In the U.S., FDA approvals for bemotrizinol—PARSOL® Shield and Tinosorb S—reopen UV filter options after decades. Companies should anticipate updates to formulations, testing plans and supplier qualification.
Digital Transformation & AI Integration
Data and AI are being embedded from plant to subsurface. Siemens, Databricks and FFT integrate Industrial Edge with the Databricks Platform to enable closed‑loop, shopfloor AI for maintenance, quality and energy. In exploration, Sinopec initiated its largest 3D continuous seismic processing and interpretation programme to accelerate targeting and development. On the customer side, UPM expanded its UPM Label Life service, embedding validated LCAs and Scope 3 data into quotes.
Energy Transition Investments
Capital is flowing to flexible power and storage. OMV Petrom took FID on Bulgaria’s Gabare project (415 MWp PV plus ~600 MWh BESS), while SPIE Belgium is integrating the Auvelais battery park (304 MWh) for grid balancing. In generation, Repsol and Masdar partnered on 705 MW of Spanish wind and solar, and Sweden’s Videberg Kraft selected Rolls‑Royce SMR for three modular reactors.
Geopolitics & Regional Competitiveness
Operating conditions remain uneven. Kemira lowers 2026 operative EBITDA outlook on Iran‑war‑linked input and logistics costs amid weak demand. In Southeast Europe, MOL’s Shareholders’ Agreement on NIS governance proceeds with OFAC approval pending, targeting supply security and refinery continuity. Industrial positioning also shifted with Westlake’s acquisition of the Wilhelmshaven plant and the all-stock merger of equals to form OlinHuntsman. Scale, location and regulatory clearance remain central to margin resilience and investment choices.
In Brief
Project Updates and Milestones
- thyssenkrupp Uhde completes İGSAŞ ammonia converter cartridge and catalyst replacement
- Evonik launches ISCC Plus‑certified ULTRASIL® eCO from Adapazarı site
- PureCycle advances food-contact PCR for New Jersey 2027 mandate
- LKAB granted environmental permit for expanded Malmberget operations
- OMV Petrom advances Gabare solar-plus-storage into development
- Statkraft to build Blåfjell Pump into Blåsjø reservoir
- Takeda’s oveporexton improved function, cognition and nighttime sleep in narcolepsy type 1
New Projects and Expansions
- Phelan Green selects Johnson Matthey for eSAF plant in South Africa
- BlueAlp and LBC Tank Terminals win €1.5M JTF grant for Rotterdam FEED
- MOL Group signs production sharing agreement for Libya O7 offshore block
- Eni and Hera launch Ravenna Environmental Hub
- Covestro launches EU-backed Bio4PURConti to scale continuous bio-based aniline production
- Worley Comprimo and BASF to deliver integrated gas treatment and SRUs for Budour Tayseer Gas Project
- thyssenkrupp AG approves spin-off of tk accelis
Mergers, Acquisitions, and Partnerships
- Mitsui Chemicals to acquire Ultradent via U.S. holding company
- Olin and Huntsman to merge as OlinHuntsman
- MAIRE/NEXTCHEM buys 70% of ETEK (owner of SISEMTEK) to add metals recovery capabilities
- Westlake acquires Wilhelmshaven PVC and VCM plant
- MOL and Serbian government sign shareholders' agreement on NIS governance
- Kemira acquires Clear Water Technologies business in California
- Siemens, Databricks and FFT integrate Industrial Edge with Databricks Platform
Innovation and Product Development
- Croda launches Malvallin™ botanical active for skin resilience
- Mitsubishi Chemical’s DURABIO chosen for Audi Q3 door switch inserts
- Petrobras and Finep launch R$150 million call for national electrolyzer development
- Trinseo wins Tongji University award for thermoplastic battery enclosure
- Croda’s Avanti Polar Lipids partners with NovoArc to expand lipid offering for pharma research
- Lilly: Jaypirca plus venetoclax‑rituximab lowers progression risk 45% in relapsed/refractory CLL/SLL
- Johnson & Johnson: TALVEY plus DARZALEX FASPRO shows superior PFS and OS in Phase 3 MonumenTAL‑3
Operational Changes and Investments
- Equinor Capital Markets Day 2026 — plan to grow energy, cash flow and returns
- Essar Energy Transition Fuels and IRH agree USD 500 million crude and product facility
- Stahl acquires Weilburger Graphics packaging coatings business in Brazil
- Sinopec and Inner Mongolia sign comprehensive strategic cooperation agreement
- Repsol and Masdar partner on €849m, 705 MW Spanish renewables portfolio
- Exolum starts operations at Madeira Airport, to invest €4.5m+ in fuel facilities
- Air Liquide and ArianeGroup renew industrial partnership with two Ariane 6 contracts
Sustainability and Environmental Initiatives
- Sinopec selected for 2026 low‑carbon case
- UPM Adhesive Materials 2025 Climate Review: emissions cuts and value-chain collaboration
- Aurubis Hamburg opens high-capacity RDE exhaust and filter system
- Evonik launches low‑carbon peracetic acid for Europe
- WuXi Biologics included in S&P Global Sustainability Yearbook (China) for fourth consecutive year
- European Commission secures stronger MSR safeguards for ETS2 (buildings & road transport)
- DuPont: U.S. healthcare sites now on 100% renewable electricity
Financial Performance and Strategy
- Symrise renews and ups €750m revolving credit facility
- Kemira lowers 2026 operative EBITDA outlook after Iran war-driven cost rises
- Mitsui Chemicals — Developing Dental Materials M&A as a Third Growth Pillar
Regulatory and Compliance Updates
- BASF’s Tinosorb S (bemotrizinol) approved by FDA as first new U.S. sunscreen active in 27 years
- Roche VENTANA PTEN (SP218) FDA-cleared as PTEN companion diagnostic in prostate cancer
- Merck: FDA approves KEYTRUDA and KEYTRUDA QLEX with WELIREG for adjuvant ccRCC
- Chugai files Tecentriq for maintenance therapy after definitive chemoradiotherapy in locally advanced esophageal cancer
- GSK’s momelotinib gains orphan drug status in US and EU for VEXAS
- Johnson & Johnson’s IMAAVY shows rapid, durable hemoglobin gains in Phase 2/3 wAIHA trial
- Novo Nordisk: Wegovy pill approved in UK as first daily GLP-1 weight-loss tablet in Europe
Workforce and Corporate Social Responsibility (CSR)
chemXplore
chemxplore.com
1e Pauwenlandstraat 12
7413ZA Deventer
The Netherlands
Dutch Chamber of Commerce number 82353735